1	Immune	immune	_	_	_	_	_	_	_
2	hyperactivation	hyperactivation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	HIV-1-infected	hiv-1-infected	_	_	_	_	_	_	_
5	T	t	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	mediated	mediate	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	Tat	Tat	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	CD28	cd28	_	_	_	_	_	_	_
13	pathway	pathway	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	Human	human	_	_	_	_	_	_	_
2	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
3	virus-type	virus-type	_	_	_	_	_	_	_
4	1	1	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	HIV-1	HIV-1	_	_	_	_	_	_	_
7	)	)	_	_	_	_	_	_	_
8	infection	infection	_	_	_	_	_	_	_
9	is	be	_	_	_	_	_	_	_
10	characterized	characterize	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	chronic	chronic	_	_	_	_	_	_	_
14	state	state	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	immune	immune	_	_	_	_	_	_	_
17	hyperactivation	hyperactivation	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	patients	patient	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Infection	infection	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	human	human	_	_	_	_	_	_	_
4	peripheral	peripheral	_	_	_	_	_	_	_
5	blood	blood	_	_	_	_	_	_	_
6	lymphocytes	lymphocyte	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	HIV-1	HIV-1	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	vitro	vitro	_	_	_	_	_	_	_
11	resulted	result	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	increased	increase	_	_	_	_	_	_	_
14	interleukin-2	interleukin-2	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	IL-2	il-2	_	_	_	_	_	_	_
17	)	)	_	_	_	_	_	_	_
18	secretion	secretion	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	response	response	_	_	_	_	_	_	_
21	to	to	_	_	_	_	_	_	_
22	T	t	_	_	_	_	_	_	_
23	cell	cell	_	_	_	_	_	_	_
24	activation	activation	_	_	_	_	_	_	_
25	via	via	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	CD3	cd3	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	CD28	cd28	_	_	_	_	_	_	_
30	receptors	receptor	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	Expression	expression	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	HIV-1	HIV-1	_	_	_	_	_	_	_
5	transactivator	transactivator	_	_	_	_	_	_	_
6	Tat	Tat	_	_	_	_	_	_	_
7	recapitulated	recapitulate	_	_	_	_	_	_	_
8	this	this	_	_	_	_	_	_	_
9	phenotype	phenotype	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	was	be	_	_	_	_	_	_	_
12	associated	associate	_	_	_	_	_	_	_
13	with	with	_	_	_	_	_	_	_
14	increased	increase	_	_	_	_	_	_	_
15	IL-2	il-2	_	_	_	_	_	_	_
16	secretion	secretion	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	response	response	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	costimulation	costimulation	_	_	_	_	_	_	_
21	with	with	_	_	_	_	_	_	_
22	CD3	CD3	_	_	_	_	_	_	_
23	plus	plus	_	_	_	_	_	_	_
24	CD28	cd28	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	IL-2	il-2	_	_	_	_	_	_	_
2	superinduction	superinduction	_	_	_	_	_	_	_
3	by	by	_	_	_	_	_	_	_
4	Tat	Tat	_	_	_	_	_	_	_
5	occurred	occur	_	_	_	_	_	_	_
6	at	at	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	transcriptional	transcriptional	_	_	_	_	_	_	_
9	level	level	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	was	be	_	_	_	_	_	_	_
12	mediated	mediate	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	CD28-responsive	cd28-responsive	_	_	_	_	_	_	_
16	element	element	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	IL-2	il-2	_	_	_	_	_	_	_
20	promoter	promoter	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	was	be	_	_	_	_	_	_	_
24	exclusively	exclusively	_	_	_	_	_	_	_
25	dependent	dependent	_	_	_	_	_	_	_
26	on	on	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	29	29	_	_	_	_	_	_	_
29	amino	amino	_	_	_	_	_	_	_
30	acids	acid	_	_	_	_	_	_	_
31	encoded	encode	_	_	_	_	_	_	_
32	by	by	_	_	_	_	_	_	_
33	the	the	_	_	_	_	_	_	_
34	second	second	_	_	_	_	_	_	_
35	exon	exon	_	_	_	_	_	_	_
36	of	of	_	_	_	_	_	_	_
37	Tat	Tat	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

